Immunoprecise Antibodies Ltd Cash Flow Reinvestment Rate
Immunoprecise Antibodies Ltd cash flow reinvestment rate. Immunoprecise Antibodies Ltd (IPA) has a Cash Flow Reinvestment Rate of 3.25x as of October 2020, reinvesting $1.43 Million (capex $715.21K plus investments $-715.21K) from operating cash flow of $440.23K. Explore how well can Immunoprecise Antibodies Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Immunoprecise Antibodies Ltd (2016–2016)
Cash flow reinvestment rate of Immunoprecise Antibodies Ltd from 2016 to 2016. Historical reinvestment intensity for Immunoprecise Antibodies Ltd across 1 annual periods. Explore Immunoprecise Antibodies Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Immunoprecise Antibodies Ltd Cash Flow Reinvestment Rate by Year (2016–2016)
Immunoprecise Antibodies Ltd cash flow reinvestment rate by year from 2016 to 2016. Year-by-year capital reinvestment analysis for Immunoprecise Antibodies Ltd. For the full cash flow conversion analysis, see cash flow conversion of Immunoprecise Antibodies Ltd.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.06x | $17.48K | $284.09K | $17.48K | — |